Drug found to lower fatal brain disease protein for 1st time
An international drug trial involving 46 patients has reported the successful use of a drug for lowering protein levels related to the Huntington's disease, an inherited disorder that results in death of brain cells. Researchers claimed it was the first time the mutant huntingtin protein known to cause Huntington's disease has been lowered in the nervous system of patients.